Previously, TIMP4 has been demonstrated to be upregulated in breast cancer [17], prostate cancer [18], glioblastoma [19], and head and neck squamous cell carcinoma [20]; whereas, low TIMP4 levels have been observed in patients with pancreatic cancer. This evidence concerns the gene TIMP4 and breast carcinoma.